Diagnostic Dilemmas in the Patient With Tardive Dyskinesia

Formulate an approach to diagnose patients with tardive dyskinesia.
Greg Mattingly, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 6.77 MB
Released: June 21, 2021


Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant provided by
Neurocrine Biosciences

Related Content

Clinical Care Options (CCO) commentary by Jonathan M. Meyer, MD, on VMAT2 inhibitors in TD and anticholinergic exacerbation of TD symptoms.

Jonathan M. Meyer, MD Released: July 8, 2021

Slides from a presentation that formulates an approach to select the right treatment for patients with tardive dyskinesia.

Manish Kumar Jha, MD Released: June 17, 2021

Clinical Care Options (CCO) commentary by Rifaat S. El-Mallakh, MD, on the differential diagnosis of tardive dyskinesia

Rif S. El-Mallakh, MD Released: June 8, 2021

Clinical Care Options (CCO) commentary by Joseph P. McEvoy, MD, on the assessment of tardive dyskinesia via telepsychiatry

Joseph P. McEvoy, MD Released: May 4, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.